Table 1 Cumulative incidence rate (95% CI) for HSIL and ASCUS based on HPV mRNA status and HR-HPV DNA types at baseline
From: 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
| CIR | HPV RNA pos | HPV mRNA neg | HPV DNA 16/18 | HPV DNA other than 16/18 |
|---|---|---|---|---|
| HSIL positive | 29.7% (24.8–30) | – | 14.6% (13.3–22.7) | 18.5% (13.2–23.7) |
| ASCUS positive | 59.9% (57.3–66.2) | 26.1% (16.5–35.9) | 64.9% (47.5–72.9) | 51.1% (43.1–63.8) |